Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin for Prevention of Acute Kidney Injury in ICU Patients
NCT06547892Phase 2Recruiting
- Sponsor
- HCor
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of vasopressin in acute kidney injury (AKI), sponsored by HCor. Started Apr 2025; status: recruiting.
02
Drugs
vasopressin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06547892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06547892.